Published in Orv Hetil on December 21, 1969
Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies. Ann Thorac Surg (2001) 1.52
Lymphocyte surface immunoglobulins in autoimmune diseases. Lancet (1973) 1.11
The effect of single large dose hydrocortisone treatment on IgM and IgG antibody production, morphological distribution of antibody producing cells and immunological memory. Immunology (1971) 0.99
Ligand inhibition studies on the role of Fc receptors in antibody-dependent cell-mediated cytotoxicity. Mol Immunol (1984) 0.93
Myasthenia gravis: effect of thymectomy in 425 patients. A 15-year experience. Eur J Cardiothorac Surg (1990) 0.91
Antibody dependent and spontaneous lymphocyte mediated cytotoxicity in normal subjects, patients with SLE, and malignancies. Acta Med Acad Sci Hung (1977) 0.87
HL-A and systemic lupus erythematosus. Haematologia (Budap) (1973) 0.86
Ethyl apovincaminate therapy in neurovascular diseases. Arzneimittelforschung (1976) 0.86
Secretagogue globulins in the blood of duodenal ulcer patients. Acta Med Acad Sci Hung (1973) 0.86
Fine structural studies in myasthenia gravis. II. Lesions of the neuromuscular junction. Eur Neurol (1973) 0.84
Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis. Hum Immunol (1982) 0.83
Effect of phytohaemagglutinin on plaque forming cells in the mouse spleen. Nature (1969) 0.83
Fine structural studies in myasthenia gravis. I. Muscle fibre lesions. Eur Neurol (1973) 0.82
Data on the oculopharyngeal syndrome. A clinicopathological study. Eur Neurol (1973) 0.81
[Anthracosis in members of the aristocracy and mummies in Hungary]. Orv Hetil (1997) 0.81
Letter: Rosette stimulation by plant mitogens. Lancet (1973) 0.81
Benefit of thymectomy in immune diseases other than myasthenia. Lancet (1984) 0.81
Characterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas. Eur Cytokine Netw (2001) 0.80
[Association between cumulative familial incidence of type I diabetes and rheumatoid arthritis]. Orv Hetil (1985) 0.80
Lymphocyte surface immunoglobulins in Hodgkin's disease. N Engl J Med (1973) 0.80
Dominantly inherited familial myasthenia gravis as a separate genetic entity without involvement of defined candidate gene loci. Int J Mol Med (2001) 0.80
Fine structural alterations of muscle fibers in diseases accompanied by myotonia. Beitr Pathol (1975) 0.79
Non-T-cell resistance against a mouse Moloney lymphoma. Int J Cancer (1976) 0.79
Effect of histamine receptor blocking on human antibody-dependent cell-mediated cytotoxicity. Scand J Immunol (1981) 0.79
Resynthesis of trypsinized sheep red blood cell receptors on human lymphocytes: comparison of the effects of immunopotentiators of biological and synthetic origin in vitro. Immunopharmacology (1981) 0.79
Mastomys natalensis as an experimental host for Brugia malaye subperiodic. Southeast Asian J Trop Med Public Health (1975) 0.79
Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates. Clin Neuropathol (1986) 0.78
Myasthenia gravis: a quantitative evaluation system. Disability status scale (DSS) applied for myasthenia gravis. Eur Neurol (1976) 0.78
Induction of anti-F(ab)2 gamma antibodies by buffy coat transfusions and their effect in kidney transplantation. Transplant Proc (1990) 0.78
Morphologic and clinico-pathologic features of thymus tumours. Acta Morphol Acad Sci Hung (1981) 0.78
Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia. Acta Haematol (2001) 0.78
Myasthenia gravis: mitotic activity of thymus-dependent and blood-lymphocytes. Acta Med Acad Sci Hung (1976) 0.77
Systemic lupus erythematosus caused by hydantoin preparations. Ann Immunol Hung (1972) 0.77
[Ultrastructure of the thymus and neuromuscular junction in myasthenic and non-myasthenic patients]. Morphol Igazsagugyi Orv Sz (1978) 0.77
Effect of histamine-receptor blocking on human spontaneous lymphocyte-mediated cytotoxicity. Scand J Immunol (1981) 0.77
Effect of phytohaemagglutinin and concanavalin A on human rosette-forming cells. Experientia (1974) 0.77
Myasthenia gravis: ALG treatment of seriously ill patients. Eur Neurol (1975) 0.77
The effect of thyrotropic hormone treatment on the epiphyseal cartilage of the white rat. Acta Morphol Acad Sci Hung (1969) 0.76
High anti-paternal cytotoxic T-lymphocyte precursor frequencies in women with unexplained recurrent spontaneous abortions. Hum Reprod (2001) 0.76
Altered polyamine levels in skeletal muscle of patients with myasthenia gravis. Clin Neuropathol (1994) 0.76
Effect in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity. Clin Immunol Immunopathol (1982) 0.76
Genetic polymorphism of the Gypsy population in Hungary as based on studies of red blood cell antigens. Haematologia (Budap) (1985) 0.76
[In vitro study on the absorption capacity of the small intestine following supraletal x-ray irradiation]. Strahlentherapie (1966) 0.76
HLA-G gene polymorphism in the normal population and in recurrent spontaneous abortion in Hungary. Transplant Proc (1999) 0.76
Retroperitoneal plasmocytic giant lymph node hyperplasia. J R Soc Med (1984) 0.75
[Management of multinodular non-toxic goiter]. Orv Hetil (1994) 0.75
Myasthenia gravis: long-term prognostic value of thymus lactate dehydrogenase isoenzyme pattern of hyperplastic thymus and thymoma. J Neurol Neurosurg Psychiatry (1985) 0.75
Chemotherapeutic studies on experimental Schistosoma mansoni infection of Mastomys natalensis. Bull World Health Organ (1971) 0.75
Immunosuppressive therapy of myasthenia gravis. Acta Med Acad Sci Hung (1970) 0.75
[Value of the Reflomat method]. Orv Hetil (1976) 0.75
[The use of cell migration inhibition in the study of cellular autoimmune response]. Orv Hetil (1972) 0.75
[The diary of Philip Blaiberg]. Orv Hetil (1970) 0.75
Functional changes of the adrenal gland after supralethal total-body irradiation. Radiobiol Radiother (Berl) (1967) 0.75
[Suppressibility of the thyroid function following radioiodine therapy of hyperthyroidism. When is Basedow-Graves disease completely cured?]. Orv Hetil (1972) 0.75
Treatment of polycythaemia vera with Myelobromol. Ther Hung (1969) 0.75
[Diagnostic significance of the rheumatoid rosette test]. Orv Hetil (1973) 0.75
Immune reactivity in subjects remaining tuberculin-negative after repeated BCG vaccination. Acta Med Acad Sci Hung (1976) 0.75
[A case of chronic candidiasis treated with transfer factor]. Fogorv Sz (1975) 0.75
Steroid treatment of lupus nephropathy: results of 60 cases. Acta Med Acad Sci Hung (1967) 0.75
[Immunosuppressive therapy of uveitis with corticosteroids and cytostatic drugs]. Orv Hetil (1972) 0.75
[Characteristics of phytohemagglutinin reactivity of human lymphocytes]. Orv Hetil (1977) 0.75
[Immunological status of patients with Basedow-Graves disease treated with radio-iodine]. Orv Hetil (1972) 0.75
Cytotoxic effect of anti-H-2 and anti-Ia antisera on human B and T cells. Scand J Immunol (1977) 0.75
Effects of lymphocytotoxins of systemic lupus erythematosus (SLE) sera on T and B lymphocytes. Acta Med Acad Sci Hung (1975) 0.75
Observations with 5-hydroxyurea in the management of polycythaemia vera. Ther Hung (1972) 0.75
[Changes in the adrenal cortical function under the effect of supralethal total body irradiation]. Orv Hetil (1966) 0.75
[Tuberculin sensitivity tests, using leukocyte migration inhibition, in patients with autoimmune diseases undergoing immunosuppressive therapy]. Orv Hetil (1973) 0.75
[Comparative studies on the protective mechanism of cysteamine and AET in "intestinal irradiation death"]. Strahlentherapie (1965) 0.75
[Therapy of polycythemia rubra vera using Zitostop]. Orv Hetil (1970) 0.75
[Studies on the cytotoxicity of lymphocytes in ulcerative colitis]. Z Gastroenterol (1975) 0.75
[Experimental proof on the mechanism of origine of functional atelectasis in bronchial stress]. Z Tuberk Erkr Thoraxorg (1966) 0.75
[Skin transplantation experiments after irradiation with high doses]. Strahlentherapie (1967) 0.75
[Treatment of chronic myeloid leukemia with Myelobromol]. Orv Hetil (1967) 0.75
[The use of immunospecific rosette formation inhibition in the comparative study of 2 prednisolone derivatives]. Orv Hetil (1973) 0.75
R-74 treatment of autoimmune myositis. Acta Med Acad Sci Hung (1970) 0.75
The effect of phytohaemagglutinin on plaque forming cells in the mouse spleen and on skin graft rejection. Folia Biol (Praha) (1969) 0.75
New cytostatic drugs in the management of polycythaemia vera. Acta Med Acad Sci Hung (1971) 0.75
[Results of radioactive phosphorus treatment of 50 patients with erythremia]. Probl Gematol Pereliv Krovi (1969) 0.75
Potentiation of glibenclamide-induced insulin release by calcium infusion. Diabetologia (1977) 0.75
[Diagnosis of the pathogenesis of autoimmunity]. Orv Hetil (1970) 0.75
[The treatment of autoimmune myositis with R-74]. Orv Hetil (1970) 0.75
[Study of human antibody-dependent cellular cytotoxicity (ADCC) in an allogenic system]. Orv Hetil (1977) 0.75
[Hypothyreosis after I-131 therapy of Graves-Basedow disease]. Orv Hetil (1975) 0.75
[Our experience with monocomponent insulin therapy]. Orv Hetil (1977) 0.75
Protective effect of anti-mouse-skin-epithelium rabbit-IgG on survival of mouse-skin homografts. Acta Med Acad Sci Hung (1973) 0.75
[Experience with the 5-hydroxyurea therapy of polycythemia rubra vera]. Orv Hetil (1972) 0.75
[Cytotoxic effect of human blood lymphocytes in homologous tissue culture]. Orv Hetil (1972) 0.75
[Diabetic ketoacidosis treated with low doses of intravenous insulin]. Orv Hetil (1977) 0.75
Immunosuppressive effects of cytostatic diastereomeric dibromhexitols. Folia Biol (Praha) (1969) 0.75
The treatment of autoimmune diseases. Ther Hung (1977) 0.75
[Recovery from chronic bone marrow aplasia in a young mother after injection of amniotic sac and liver cells from her own 22mm sized fetus. Preliminary report]. Orv Hetil (1973) 0.75
Connection between the anti-organ and anti-nuclear titres of antilymphocyte sera and their inhibitory effect on skin graft rejection in mice. Haematologia (Budap) (1971) 0.75
Cellular immune reactivity to nuclear antigens in systemic lupus erythematosus. Acta Med Acad Sci Hung (1976) 0.75
[Cytogenetic studies in chronic myeloid leukemia]. Orv Hetil (1975) 0.75
[Cell mediated and humoral immune response evoked by human valscular wall antigens]. Orv Hetil (1975) 0.75
[The rosette forming lymphoid cell]. Orv Hetil (1972) 0.75
In-vitro sensitivity to cytostatics in chronic myeloid leukaemia. Acta Med Acad Sci Hung (1973) 0.75
Experiences with a new tuberculosis diagnostic test (percutaneous mycobacterium test) in the diagnosis and detection of tuberculosis. Ther Hung (1969) 0.75
New cytostatic drugs in the management of polycythaemia vera. Ther Hung (1972) 0.75